Skip to main content
Premium Trial:

Request an Annual Quote

Marc Jones

Atlas Genetics has announced today that it has appointed Marc Jones as COO and CFO. Jones will lead Atlas' finance and operations functions, as well as new channel development. Prior to Atlas, Jones served as COO and CFO of Good Start Genetics, where he raised successive rounds of capital. Jones also served as CFO of T2 Biosystems, where he oversaw the company's public offering and helped drive commercialization of the company's first FDA IVD product. Previously, Jones was CFO at Crashlytics, Ivenix, and Chil Semiconductor.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.